Latest Funding Arrangements News

Peninsula Energy reports progress on its Lance Project’s Central Processing Plant and announces the termination of three sales contracts as part of a strategic reset plan, while engaging in funding discussions to support completion.

Latitude 66 Limited’s maiden reverse circulation drilling at the K6 Prospect in Finland confirms a 2.5km mineralised gold-cobalt trend, demonstrating both promising exploration potential and a new efficient drilling method for the region.

Chimeric Therapeutics has secured a $2.5 million advance against its FY25 R&D tax incentive, bolstering funding for its clinical trial pipeline and operational needs. This move complements recent capital raises and underscores the company’s strategic financial management amid its oncology-focused cell therapy development.

Titanium Sands Limited has locked in a $600,000 convertible loan facility from major shareholders to fund environmental studies and progress its Mannar Heavy Mineral Project. This funding milestone follows recent regulatory approvals and marks a critical step forward for the company.

Havilah Resources reports significant progress on its copper-gold-cobalt projects Kalkaroo and Mutooroo, alongside promising regional exploration and strategic funding efforts.

QPM Energy has refinanced its debt with two new funding agreements totaling $70 million from Dyno Nobel, strengthening its balance sheet and enabling accelerated growth in its gas supply and energy portfolio.

West Wits Mining Limited (WWI) has addressed recent spikes in its share price and trading volume, linking the activity to funding developments, a strong gold price, and positive market commentary.

ASPI Isotopes Inc. has agreed to acquire Renergen Limited in an all-share deal, creating a vertically integrated global entity focused on critical materials for semiconductors, medical isotopes, and green energy. The transaction addresses Renergen’s liquidity challenges and positions the combined company for growth across multiple strategic sectors.

KPMG's latest actuarial report reveals a slight increase in asbestos-related disease liabilities for former James Hardie entities, driven by a notable rise in mesothelioma claims and evolving actuarial assumptions.

Chimeric Therapeutics has raised $6.6 million through a discounted two-tranche placement to accelerate its promising CAR-T and NK cell therapy clinical programs. The capital raise, strongly backed by institutional and professional investors, signals growing confidence in the company’s oncology pipeline.

Mantle Minerals has secured a $65,000 co-funded drilling grant from the WA Government to advance its Mt Berghaus gold exploration in the Mallina Basin.

Hastings Technology Metals has entered a binding agreement with Wyloo to form a 60:40 joint venture on the Yangibana Rare Earths and Niobium Project, with Wyloo taking the lead on funding and management. This partnership aims to de-risk project development and accelerate progress toward final investment decision.